FDA product code QMY: Computerized Behavioral Therapy Device For Treating Symptoms

QMY is the FDA product code for computerized behavioral therapy device for treating symptoms. It is a Class II device, regulated under 21 CFR 876.5960 and reviewed by the Gastroenterology and Urology panel. FDA has cleared 2 510(k) submissions under QMY, from 2 different applicants. The average 510(k) review took 113 days (median 113). 1 De Novo request was granted under it.

Definition

A computerized behavioral therapy device for treating symptoms of gastrointestinal conditions is a prescription device intended to provide a computerized version of condition-specific therapy as an adjunct to standard of care treatments to patients with gastrointestinal conditions.

Classification

FieldValue
Device nameComputerized Behavioral Therapy Device For Treating Symptoms
Device classClass II
Regulation21 CFR 876.5960
Review panelGU — Gastroenterology and Urology
Medical specialtyGastroenterology, Urology
Premarket route510(k)

510(k) clearances per year for QMY

YearClearancesAvg. review days
20212113

Compare with all 510(k) review times · Search every QMY clearance

Top QMY applicants

ApplicantClearancesLatest
Metame Health, Inc.12021-11-24
Mahana Therapeutics, Inc.12021-06-02

Most recent QMY clearances

510(k)ApplicantDeviceDecision dateReview days
K211463Metame Health, Inc.Regulora2021-11-24197
K211372Mahana Therapeutics, Inc.Mahana Parallel Digital Cognitive Behavioral Therapy (CBT) Mobile Application for Irritable Bowel Syndrome (IBS)2021-06-0229

Recalls for QMY devices

openFDA lists no recalls for product code QMY.

Frequently asked questions

What is FDA product code QMY?

QMY is the FDA product code for computerized behavioral therapy device for treating symptoms. It is a Class II device, regulated under 21 CFR 876.5960 and reviewed by the Gastroenterology and Urology panel.

What device class is QMY?

Class II, regulation 21 CFR 876.5960. Typical premarket route: 510(k).

How long does a 510(k) take for product code QMY?

Across 2 cleared submissions the average was 113 days from receipt to decision (median 113).

Which companies have the most QMY clearances?

Metame Health, Inc. (1); Mahana Therapeutics, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Gastroenterology and Urology product codes · FDA product code lookup · 510(k) database search · 510(k) review times